Furthermore, 24-h re-stimulation of the EpiTCer activated CD8+ T cells with ANRU tumor cells resulting in a more efficient tumor recognition than the 6-h re-stimulation, at all tested bead/DC ratios, as measured by degranulation (CD107a) and IFNγ production. The gene discussed is CD8A; the disease is neoplasm.